Compared with those in NASH Recip mice, noticeable activated FXR signaling in the livers of (NASH + DSF) Recip mice was observed whereas remained unchanged in the intestine (Supplementary Fig. 12a, c, e, f). This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatohepatitis.